ArticleFrontiers in pharmacology2021

A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe.

Jeroen V Koomen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.